6^th Asia-Pacific Pharma Congress July 11-13, 2016 Kuala Lumpur, Malaysia

The importance of intellectual property law is well established at all levels-statutory, administrative and judicial. It lays down minimum standards for protection and enforcement in member countries which are required to promote effective and adequate protection of intellectual property rights with a view to reducing distortions and impediments to international trade.

The Agreement provides norms and standards in respect of following areas of intellectual properties are Patents, Trademarks, copyrights, Geographical indications, Industrial designs.

The global intellectual property market will move a step close to maturity when IP laws are followed, information transparency is achieved, and strategic thinking is given importance. Leading economies have already passed laws to encourage this. In the United States, for instance, introduced the America Invents Act in September 2011. The act is aimed at enhancing product quality by collecting third party patent-related information and registering it with the United States Patent and Trademark Office (USPTO).

Although most pharmacognostic studies focus on plants and medicines derived from plants, other types of organisms are also regarded as pharmacognostically interesting, in particular, various types of microbes (bacteria, fungi, etc.), and recently various marine organisms.

Medical Ethnobotany: The study of the traditional use of plants for medicinal purposes

Ethnopharmacology: The study of the pharmacological qualities of traditional medicinal substances

Phytotherapy: The study of medicinal use of plant extracts

Phytochemistry: The study of chemicals derived from plants (including the identification of new drug candidates derived from plant sources).

Zoopharmacognosy: The process by which animals self-medicate, by selecting and using plants, soils, and insects to treat and prevent disease.

Marine Pharmacognosy: The study of chemicals derived from marine organisms. 

It is estimated that about 70% of the supply of herbal raw material for Ayurveda and other homeopathic medicines in India comes from the wild. The global market for botanical and plant-derived drugs was valued at $23.2 billion in 2013 and $24.4 billion in 2014. This total market is expected to reach $25.6 billion in 2015 and nearly $35.4 billion in 2020, with a compound annual growth rate (CAGR) of 6.6% from 2015 to 2020. 

It encompasses a molecular evaluation of drug metabolism and transport processes and the study of genetic, environmental and disease-related factors that regulate or perturb those processes, as well as the fundamental mathematical relationships between enzyme/transporter function, blood concentration-time profiles and the spectrum of pharmacological effects.

The global market for contract pharmaceutical manufacturing, research and packaging totalled $248.5 billion in 2014 and is projected to approach $352.8 billion by 2019, registering a compound annual growth rate (CAGR) of 7.3% through 2019.

It is a part of science and technology about the control of matter on the atomic and molecular scale - this means things that are about 100 nanometres or smaller.

Nanotechnology brings together scientists and engineers from many different subjects, such as applied physics, materials science, interface and colloid science, device physics, chemistry, Supramolecular chemistry (which refers to the area of chemistry that focuses on the non-covalent bonding interactions of molecules), self-replicating machines and robotics, chemical engineering, mechanical engineering, biology engineering, and electrical engineering.

The global market for nanotechnology was valued at $22.9 billion in 2013 and increased to about $26 billion in 2014. This market is expected to reach about $64.2 billion by 2019, a compound annual growth rate (CAGR) of 19.8% from 2014 to 2019. 

Industrial pharmacy is a discipline which includes manufacturing, development, marketing and distribution of drug products including quality assurance of these activities.

The research topics are focussed on solving current general problems in pharmaceutical industry, such as formulation and characterisation of sticky amorphous drugs, problem-solving for paediatric medicines and miniaturisation of manufacturing processes.

The drugs fulfil the promise of modern medicine by enriching and often extending a patient’s quality of life Specialty pharmaceutical spending is on the rise and is expected to increase from approximately $55 billion in 2005 to $1.7 trillion in 2030, according to the Pharmaceutical Care Management. 

Pharmacology is the study of how medicine and other things have an effect on living organisms and change how they function. The field encompasses drug composition and properties, synthesis and drug design, molecular and cellular mechanisms, organ/systems mechanisms, signal transduction/cellular communication, molecular diagnostics, interactions, toxicology, chemical biology, therapy, and medical applications and anti-pathogenic capabilities.

The global pharmacology market was valued at $346.2 million in 2013 and $360.9 million in 2014. This market is expected to grow to $412.7 million by 2019, a compound annual growth rate (CAGR) of 2.7%.

Pharmaceutical Chemistry is a core discipline within Pharmaceutical Sciences. It is centrally engaged in the drug discovery process, mainly focusing on lead finding, lead optimisation and structure-activity relationship investigations, using technologies of computer-aided drug design, natural products chemistry, synthetic organic chemistry, and biochemical molecules approaches in a trans-disciplinary combination which is generally known by the term "Medicinal Chemistry".

The pharmaceutical market was valued at $1 trillion in 2013, according to IMS. The market grew at a 4% compound annual growth rate (CAGR) from 2009 to 2013. It grew well in 2010 and 2011 before a decline in growth in 2012 and 2013.

Pharmaceutical analysis is a process or a sequence of processes to identify and/or quantify a substance or drug, the components of a pharmaceutical solution or mixture or the determination of the structures of chemical compounds used in the formulation of pharmaceutical product. This is mainly used for the separation of the components from the mixture and for the determination of the structure of the compounds. 

The global revenue of the market research industry exceeded 40 billion U.S. dollars in 2013, rising year-on-year since it experienced a slight dip in 2009 during the Great Recession. In 2013, Europe generated the largest share of market research revenue at 40 percent, or 16 billion U.S. dollars, very closely followed by North America with 39 percent. Despite contributing the most revenue that year, Europe also saw the largest decline in revenue over the previous year, falling by 1.4 percent.

It includes the research and development of anti-infective agents, the use of microorganisms to detect mutagenic and carcinogenic activity in prospective drugs, and the use of microorganisms in the manufacture of pharmaceutical products like insulin and human growth hormone.

Pharmaceutical microbiology is additionally involved with the validation of disinfectants, according to standards, to evaluate the efficacy of disinfectants in suspension, on surfaces, and through field trials.

The consumables, equipment and technology markets in the microbiology industry totalled nearly $7.7 billion in 2012. This total is expected to grow from $8.5 billion in 2013 to $11.4 billion in 2018, with a compound annual growth rate (CAGR) of 6.1% for the five-year period, 2013 to 2018.

Pharmaceutical biotechnology has emerged as one of the major disciplines for drug discovery and development. Today the shape and vision of pharmaceutical aspects and challenges have completely changed, and the prefix “pharma”  can also be accepted as a synonym for integrated life science approaches, ranging from genetics to molecular biology to diagnostics, with the common goal of delivering the best drug to the patient by biotechnological techniques.

Global market for biotechnology in the life sciences is estimated at over $29.6 billion for 2014. Pharmaceutical Biotechnology will show steady sustained growth at 20.7%. This market is forecast to grow to more than $79.8 billion by 2019 to register a healthy compound annual growth rate (CAGR) of 22%. 

By controlling information flow through biochemical signalling and the flow of chemical energy through metabolism, biochemical processes give rise to the complexity of life. Over the last 40 years, biochemistry has become so successful at explaining living processes that now almost all areas of the life sciences from botany to medicine are engaged in biochemical research.

Today, the main focus of pure biochemistry is in understanding how biochemical molecules give rise to the processes that occur within living cells, which in turn relates greatly to the study and understanding of whole organisms. Biochemistry has advanced, especially since the mid-20th century, with the development of new techniques such as chromatography, X-ray diffraction, dual polarisation interferometry, NMR spectroscopy, radio isotopic labelling, electron microscopy, and molecular dynamics simulations. These techniques allowed for the discovery and detailed analysis of many molecules and metabolic pathways of the cell, such as glycolysis and the Krebs cycle.

The report analyses the worldwide markets for Laboratory Chemical Reagents in US$ Million by the segments like Biochemistry and Molecular Biology.  Annual estimates and forecasts are provided for the period 2013 through 2020. Employment of biochemists and biophysicists is projected to grow 8 percent from 2014 to 2024, about as fast as the average for all occupations. 

Recognition of the practice of clinical pharmacy by the profession has led to our professional bodies publishing statements aimed at standardising pharmacy practice. These statements were developed by the profession to bring uniformity to the practice of clinical pharmacy. However they outlined what pharmacists want from clinical pharmacy, there was little input from clinical colleagues or patients about what they wanted from clinical pharmacy. 

The global clinical pharmacy market reached nearly $3.0 billion in 2012. This market is expected to grow to nearly $3.2 billion in 2013 and $4.9 billion in 2018 with a compound annual growth rate (CAGR) of 8.8% over the five-year period, 2015 to 2020. Clinical pharmacy has a rich history of advancing practice through innovation. 

The study of pharmacy involves the effective recommendation and administration of various medications for the safety and health of patients. Hospital pharmacy is a specialization of this field that includes additional duties such as aiding doctors in applying drug therapy. The statements were developed by the profession to bring uniformity to the practice of hospital pharmacy.

Emergency department visits accounted for 7.4% of the total hospital visits in the U.S. in 2011 compared to 2.3% in 2010. Global spending on medicines is expected to increase from USD 1 trillion in 2014 to USD 1.2 trillion by 2017. Asia Pacific and Rest of the World are among the fastest growing markets for hospital pharmaceuticals due to the presence of large population base, aging population suffering from chronic diseases and increasing disposable income.

The pharmaceutical industry has provided the world with incredible medical breakthroughs. Although science continues to outpace the law, it is imperative that compliance infrastructures remain current. Effective compliance programs continue to be top of mind for industry stakeholders.  It is important that compliance programs continue to ensure that training programs are designed to effectively train management including the directors of life sciences companies.

The global pharmaceutical packaging equipment market is estimated to grow at a CAGR of 6.9% from 2015 to 2020 to reach USD 7.24 Billion by 2020. Growth in the generics market, the rising need for novel and flexible packaging equipment, growing offshore manufacturing of the pharmaceutical packaging equipment, growth of contract manufacturing and regulatory compliance mandating the replacement of old equipment are some major factors driving the growth of this market.

Asia Pacific is the third largest pharmaceutical market in the world after North America and Europe, with generics being the major driver for the pharmaceutical industry in this region, aided by factors such as the aging population and impending expiry of patented drugs. BMI's pharmaceutical expenditure forecasts show that, in general, developing countries will see a higher rate of pharmaceutical sales growth, while the growth for developed countries is lower. Countries that will experience strong growth include Vietnam (16.4%), China (15.0%), Sri Lanka (12.4%), Myanmar (12.2%) and Bangladesh (11.5%).

Pharmaceuticals mount the lion share in terms of volume, having evolved into a US $959 billion industry that generates more than 60 percent of the segment with growth expected to reach to 5.3 percent per annum between 2012 and 2017 (IMS 2013). Combined sales of prescription drugs and over-the-counter (OTC) medicines are forecast to increase from USD276.6bn in 2013 to USD384.7bn in 2018, representing a five-year compound annual growth (CAGR) of 7.0%.

World pharmaceutical market is worth US$300 billion a year, a figure expected to rise to US$400 billion within three years. The pharmaceutical industry is responsible for the development, production and marketing of medications. Thus, its immense importance as a global sector is evident. More than any other industry, the pharmaceutical sector is highly dependent on its research and development segment. Pharmaceutical companies invest 20 percent and more of their revenues in R&D measures. The United States is a traditional stronghold of pharmaceutical innovation.

The worldwide revenue of the pharmaceutical market from 2001 to 2014 was around 390.2 billion U.S. dollars. Ten years later, this figure stood at almost one trillion U.S. dollars. In 2008, global pharmaceutical revenue came to some 712 billion U.S. dollars based on quarterly exchange rates. Six years later, total revenues of the pharmaceutical market stood at almost 940 billion U.S. dollars worldwide.

A platform aimed to connect Entrepreneurs, Proposers and the Investors worldwide. It's intended to create and facilitate the most optimized and viable meeting place for engaging people in global business discussions, evaluation and execution of promising business ideas. An investor could be able to find out the highest potential investment opportunities globally, which provide good return on investment. For entrepreneurs, this would be an ideal place to find out suitable investors and partners to start and/or expand their business. Thus it is a perfect place to connect Entrepreneurs, Business Owners, Early Stage Companies and Established Corporates with National or International Investors, Corporate Investors and Potential Business Partners.